APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

NCT03165994 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Cancer
GastroEsophageal Cancer

Interventions

DRUG: APX005M
RADIATION: Radiation Therapy
DRUG: Paclitaxel
DRUG: Carboplatin
PROCEDURE: Surgical resection of tumor

Sponsor

Apexigen America, Inc.